The work and aims of AltaVoice
Exciting new treatments in myeloma
Highlights from EHA 2016 press briefings: POLLUX and EURO-SKI trials and BiTE antibodies
Do patients with CLL require CAR T-cell therapy?
TAP funded Tier study for relapsed and refractory CNS lymphoma patients